Annual Drug Patent Expirations for WYNZORA
Wynzora is a drug marketed by MC2 and is included in one NDA.
The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
